DiaSys Announces Seven International Distribution Agreements.WATERBURY, Conn.--(BUSINESS WIRE)--Nov. 24, 1997--DiaSys Corp. (NASD NASD See: National Association of Securities Dealers NASD See National Association of Securities Dealers (NASD). :DIYS) a manufacturer of medical laboratory equipment with applications in urinalysis urinalysis (y  r'ənăl`ĭsĭs), clinical examination of urine for the purpose of medical diagnosis. , microbiology and cytology cytology (sītŏl`əjē), in biology, the study of the structure of all normal and abnormal components of cells and the changes, movements, and transformations of such components. , today announced distribution agreements for the sale of DiaSys products in: Mexico, Brazil, Bolivia, Korea, the Philippines, Singapore and Australia. Each of the seven countries is managed by an independent distributor, who by agreement, will sell and service the company's laboratory workstations. Each agreement also establishes a minimum annual revenue requirement for each country. The company has already received orders for 23 workstations against such requirements. Todd M. DeMatteo, the company's president/CEO, said that DiaSys offers a very unique and cost effective method for standardizing certain laboratory diagnostic procedures. He said that internationally, the company's workstations can quickly become the required practice in countries having governmentally controlled medicine since standardized practices among all laboratories within a network is a proven method for providing better medicine at lower costs. DeMatteo further said that distribution operations have already commenced in most of the international territories in which DiaSys products are represented, and that revenue in the upcoming year should start to reflect initial market penetration Noun 1. market penetration - the extent to which a product is recognized and bought by customers in a particular market penetration - the act of entering into or through something; "the penetration of upper management by women" . DiaSys Corp. designs, develops, manufactures and distributes workstation-products which standardize and reduce the cost for analyzing urine sediment and fecal fecal /fe·cal/ (fe´k'l) pertaining to or of the nature of feces. fe·cal adj. Relating to or composed of feces. fecal pertaining to or of the nature of feces. concentrates in hospitals and private clinical laboratories throughout the world. -0- Forward looking statements in this release are made under the safe harbor Safe Harbor 1. A legal provision to reduce or eliminate liability as long as good faith is demonstrated. 2. A form of shark repellent implemented by a target company acquiring a business that is so poorly regulated that the target itself is less attractive. provisions of the Private Securities Litigation Reform Act The Private Securities Litigation Reform Act of 1995 (PSLRA) implemented several significant substantive changes affecting certain cases brought under the federal securities laws, including changes related to pleading, discovery, liability, class representation and awards fees and of 1995. Such statements are subject to certain risks and uncertainties, including without limitation, continuing sales growth, commercial success of current and new products, as well as other risks and uncertainties mentioned by the company in its filings with the Securities and Exchange Commission as prescribed by law. CONTACT: DiaSys Corporation Todd M. DeMatteo, 800/360-2003 |
|
||||||||||||||
Printer friendly
Cite/link
Email
Feedback
Reader Opinion